Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ruriko Koto, Akihiro Nakajima, Hideki Horiuchi & Hisashi Yamanaka. (2021) Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data. Modern Rheumatology 31:1, pages 261-269.
Read now
Read now
Articles from other publishers (7)
Yu Wang, Wenjing Li, Hao Wu, Yu Han, Huanzhang Wu, Zhijian Lin & Bing Zhang. (2023) Global status and trends in gout research from 2012 to 2021: a bibliometric and visual analysis. Clinical Rheumatology 42:5, pages 1371-1388.
Crossref
Crossref
Joong Kyong Ahn. (2023) Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean. Journal of Rheumatic Diseases 30:2, pages 88-98.
Crossref
Crossref
Seigo Akari, Takashi Nakamura, Kenichi Furusawa, Yuichi Miyazaki & Kazuomi Kario. (2022) The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data. The Journal of Clinical Hypertension 24:8, pages 1068-1075.
Crossref
Crossref
N. A. Koziolova & A. I. Chernyavina. (2022) Hypertension and asymptomatic hyperuricemia: algorithm of diagnostics and management (literature review). "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28:4, pages 316-327.
Crossref
Crossref
Faven Butler, Ali Alghubayshi & Youssef Roman. (2021) The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis. Journal of Personalized Medicine 11:3, pages 231.
Crossref
Crossref
Marlene Andrade-Guel, Carlos A. Ávila-Orta, Gregorio Cadenas-Pliego, Christian J. Cabello-Alvarado, Marissa Pérez-Alvarez, Pamela Reyes-Rodríguez, Fawad Inam, Dora A. Cortés-Hernández & Zoe V. Quiñones-Jurado. (2020) Synthesis of Nylon 6/Modified Carbon Black Nanocomposites for Application in Uric Acid Adsorption. Materials 13:22, pages 5173.
Crossref
Crossref
Tomohiko Ishikawa, Tatsushi Maeda, Teruo Hashimoto, Tetsuya Nakagawa, Kazuhito Ichikawa, Yasushi Sato & Yoshihiko Kanno. (2020) Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study. Clinical Drug Investigation 40:9, pages 847-859.
Crossref
Crossref